Meet Anne Wojcicki, the 23andMe founder who wants to bid on the company after stepping down as CEO
Anne Wojcicki has resigned as 23andMe's CEO. She is the sister of late YouTube CEO Susan Wojcicki and the ex-wife of Sergey Brin.
Dispensed
The CEO of an A16z-backed healthcare startup is pitching a better way to save money on obesity care
Knownwell just snagged $20 million in funding from A16z to provide lifelong obesity treatment to patients.
Women's health is gaining traction — and a top VC predicts a blockbuster IPO for Maven could pave the way for more transactions
Health startups geared toward women are gaining ground. But the space still needs more blockbuster deals to truly take off, Chrissy Farr, a VC, told BI.
Here's every healthcare startup laying off employees in 2023, from Commure to Olive AI
Digital health startups are slashing staff to stay afloat. Here are the ones that have cut employees so far in 2023, from Commure to Nomad Health.
A $6 billion healthcare-AI startup backed by General Catalyst cut staff after pledging to hire 'aggressively'
Commure cut staff in November following its merger with Athelas, a leaked email shows.
Healthcare companies are promising to help patients quit Wegovy. There's just one problem with that.
Companies like WeightWatchers and Noom say they can help workers quit GLP-1 drugs while maintaining weight loss and other health benefits. There's no evidence to back them up.
See the 20-slide pitch deck that got Merck to back an AI-powered biotech creating drugs for untreatable diseases
Pepper Bio wants to improve drug discovery for pharma companies using AI. The startup raised a $6.5 million seed round in November.
How Mark Cuban forced the biggest US pharmacy to upend its business
CVS is changing how it sells prescription drugs — and the result looks a lot like billionaire Mark Cuban's online pharmacy.
Why a giant health insurer merger is probably destined to fail
A reported tie-up of Cigna and Humana would face harsh scrutiny from the Biden administration.
Why a $1.7 billion digital-health upstart is sitting out the Ozempic craze for now
Hims & Hers is waiting out drug shortages and insurance battles as rivals struggle with prescribing the meds for weight loss.
Women are turning to Facebook for a DIY approach to getting pregnant
A vial of sperm can cost $1,000, so some people are taking different approaches to finding a sperm donor.
Weight-loss drugs just got cheaper — and better
Eli Lilly priced its new weight-loss drug Zepbound 20% lower than competitor Wegovy, an unusual move in the pharmaceutical world.
Exclusive: A private equity firm took over Calibrate for $20 million after threatening to push the once-hot healthcare startup into bankruptcy
Madryn Asset Management now owns 70% of Calibrate, while early investors saw their stakes slashed.
Once loyal Calibrate patients say they regained weight after the startup struggled to get them weight-loss meds on time
The troubled weight-loss startup is facing complaints from members who say their second year with the company was far worse than their first.
Spora Health's founder painted a rosy portrait of his healthcare startup. The reality is more complicated.
An Insider investigation into the primary-care startup Spora Health suggests the company is struggling after laying off its workers in late 2022.
Healthcare-staffing startup Nomad Health just slashed its workforce for the second time this year
Nomad Health, a platform for travel nurses, cut 25% of its staff on October 3. The company previously cut 17% of its workforce in February.
Exclusive: Weight-loss startup Calibrate is selling itself to a private equity firm as patient complaints mount
Weight-loss startup Calibrate, which prescribes drugs like Ozempic online, is selling itself to private equity firm Madryn Asset Management.
See the presentations that hot healthcare startups used to raise millions from top VCs
We compiled the pitch decks that healthcare startups like Tia, Omada, and NOCD have used to win over investors.
Hinge Health is shooting for profitability in 2024 as the physical-therapy startup prepares for an IPO
Hinge Health's CEO said the physical-therapy startup has $400 million in the bank and hopes to become profitable next year ahead of an IPO.
The cost of hot new weight-loss drugs could put some companies out of business, Blackstone exec warns
Corporate leaders are debating whether employers should pay for their workers' weight-loss drugs, which can cost more than $1,000 a month.